ArticleJournal of pain research2025
Radiofrequency Ablation of the Medial Branch Nerves for Posterior Element Pain in Chronic Vertebral Compression Fractures: An Anatomical Review and Retrospective Case Series.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic, Prognostic and Therapeutic Utility of MicroRNA-21 in Ischemic Heart Disease.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Purpose: Vertebral compression fractures (VCFs) cause significant pain and disability, particularly in the elderly and those with osteoporosis, trauma, or malignancy. Medial branch nerve radiofrequency ablation (RFA-MBN) offers a minimally invasive intervention for facetogenic pain in patients with VCFs. This retrospective case study explores the efficacy and clinical outcomes of RFA-MBN in managing VCF-associated pain. Patients and Methods: A retrospective chart review of 61 patients with confirmed chronic thoracic or lumbar VCFs who underwent RFA-MBN between 2014 and 2022 at a single academic pain center was conducted. Primary outcomes were self-reported percentage and duration of pain relief. Secondary outcomes included changes in disability index scores. Covariates such as age, gender, number, location, and cause of VCFs, PHQ-9 scores, history of prior vertebroplasty, laterality of RFA-MBN, and time to repeat ablation were evaluated. Statistical analysis was performed using linear mixed-effect models. Results: The average pain relief was 56.6% over 36.1 weeks. 67% percent of patients experienced at least 50% pain relief for three months, with 47.5% of those patients maintaining relief for six months. A higher pre-disability index was significantly associated with increased pain relief (p=0.007) while none of the other covariates above showed significant associations with the primary outcomes. Conclusion: RFA-MBN appears to provide meaningful pain relief for patients with VCFs, especially those with higher baseline disability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.